Donors

At the Center for Medicine in the Public Interest, we acknowledge the generosity of our donors and their dedication to our mission and the advancement of healthcare policy.

AbbVie Inc.

Amicus Therapeutics

APCO Worldwide

Aprecia Pharmaceuticals

BIO

Bristol Myers Squibb

ChromaDex

Ewing Marion Kauffman Foundation

Gilead Sciences, Inc.

GSK

Juul Labs

The Lilly Foundation

Merck & Co.

National Community Pharmacists Association

Novo Nordisk Inc.

Pfizer, Inc.

PhRMA

Sarepta Therapeutics

Searle Freedom Trust

Stand Together Trust

Standup4Nurses

The coronavirus could help pharma reset its reputation in Washington

The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington.... Read more

STAT
10/17/2024 12:00 AM

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub... Read more

The Washington Times
07/02/2024 12:00 AM

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers... Read more

RECENT NEWS

The coronavirus could help pharma reset its reputation in Washington

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Tort bar’s newest collateral damage: Preterm babies

DRUGWONKS BLOG

RESEARCH ISSUES